Pegadinhas (atenção especial)
Confusões comuns (o que costuma cair)
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR (Text Revision). American Psychiatric Association. 2022. DOI: 10.1176/appi.books.9780890425787
estudo: ExpertOpinion
Abrir fonteLam RW, Kennedy SH, Milev R, Baldwin DS, Ramasubbu R, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Evidence Review and Recommendations. The Canadian Journal of Psychiatry — Canadian Network for Mood and Anxiety Treatments (CANMAT). 2024; 69; 641-687. DOI: 10.1177/07067437241245384
estudo: Guideline
Abrir fontePanorama
Fatores de risco
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR (Text Revision). American Psychiatric Association. 2022. DOI: 10.1176/appi.books.9780890425787
estudo: ExpertOpinion
Abrir fonteHiperatividade do sistema de alarme (locus coeruleus, amígdala). Sensibilidade aumentada a CO2 e lactato. Condicionamento interoceptivo: sintomas corporais normais são interpretados como perigosos, desencadeando o ataque.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR (Text Revision). American Psychiatric Association. 2022. DOI: 10.1176/appi.books.9780890425787
estudo: ExpertOpinion
Abrir fonteAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR (Text Revision). American Psychiatric Association. 2022. DOI: 10.1176/appi.books.9780890425787
estudo: ExpertOpinion
Abrir fonteCritérios
Exames iniciais
Exames laboratoriais
Exames de imagem
Outros exames
Diagnóstico diferencial
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR (Text Revision). American Psychiatric Association. 2022. DOI: 10.1176/appi.books.9780890425787
estudo: ExpertOpinion
Abrir fonteObjetivos
Primeira linha (resumo)
Farmacológico — 1ª linha
Farmacológico — 2ª linha
Situações especiais
Duração
Mínimo 12-24 meses após remissão
Lam RW, Kennedy SH, Milev R, Baldwin DS, Ramasubbu R, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Evidence Review and Recommendations. The Canadian Journal of Psychiatry — Canadian Network for Mood and Anxiety Treatments (CANMAT). 2024; 69; 641-687. DOI: 10.1177/07067437241245384
estudo: Guideline
Abrir fonteRed flags
Metas terapêuticas
Lam RW, Kennedy SH, Milev R, Baldwin DS, Ramasubbu R, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Evidence Review and Recommendations. The Canadian Journal of Psychiatry — Canadian Network for Mood and Anxiety Treatments (CANMAT). 2024; 69; 641-687. DOI: 10.1177/07067437241245384
estudo: Guideline
Abrir fonteFrequência de consultas
Semanal no início, depois quinzenal/mensal
Exames de controle
Metas terapêuticas
Critérios de encaminhamento
Lam RW, Kennedy SH, Milev R, Baldwin DS, Ramasubbu R, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Evidence Review and Recommendations. The Canadian Journal of Psychiatry — Canadian Network for Mood and Anxiety Treatments (CANMAT). 2024; 69; 641-687. DOI: 10.1177/07067437241245384
estudo: Guideline
Abrir fontePrimária
Secundária
Conteúdo de estudo. Não substitui diretrizes oficiais nem decisão clínica.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR (Text Revision). American Psychiatric Association. 2022. DOI: 10.1176/appi.books.9780890425787
estudo: ExpertOpinion
Abrir fonteLam RW, Kennedy SH, Milev R, Baldwin DS, Ramasubbu R, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Evidence Review and Recommendations. The Canadian Journal of Psychiatry — Canadian Network for Mood and Anxiety Treatments (CANMAT). 2024; 69; 641-687. DOI: 10.1177/07067437241245384
estudo: Guideline
Abrir fonte